In the BioHarmony Drug Report Database
Diazoxide
Hyperstat, Proglycem (diazoxide) is a small molecule pharmaceutical. Diazoxide was first approved as Hyperstat on 1982-01-01. It is used to treat hypoglycemia and malignant hypertension in the USA. It is known to target ATP-sensitive inward rectifier potassium channel 8, ATP-sensitive inward rectifier potassium channel 11, and nicotinamide phosphoribosyltransferase.
Trade Name
|
Hyperstat, Proglycem |
|---|---|
Common Name
|
diazoxide |
ChEMBL ID
|
CHEMBL181 |
Indication
|
hypoglycemia, malignant hypertension |
Drug Class
|
Image (chem structure or protein)